MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LENTZ, D. J.
Right arrow Articles by EYRING, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LENTZ, D. J.
Right arrow Articles by EYRING, E. M.

Molecular Pharmacology, Vol 9, 514-519, Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics

Kinetics of Aqueous Iron(III) Complexation by Desferrioxamine B

DAVID J. LENTZ 1, GARY H. HENDERSON 1, and EDWARD M. EYRING 1

1 Department of Chemistry, University of Utah, Salt Lake City, Utah 84112

Light absorbance stopped-flow rate measurements have been made of the formation of a complex between iron(III) and desferrioxamine B in 0.1 M ionic strength, acidic, aqueous solution at and below 36°. The over-all second-order rate constant for the reaction iron(III) + desferrioxamine B rarr 1:1 complex is k2 = 2.5 x 103 M-1 sec-1 at pH 3.92 and 36°. This is of the same order of magnitude as previously reported rate constants for aqueous iron(III) complexation by various ligands. The over-all second-order rate constant for the same reaction in blood plasma for pH values ranging from 4.1 to 7.1 at 36° is the same as in aqueous solution to within experimental error. Thus, at physiological pH and temperatures the actual complexation reaction is sufficiently rapid that one may expect this ligand attached to a polymeric substrate to remove excess iron from blood more rapidly than the blood can be circulated in an extracorporeal cleansing device.

Note:
ACKNOWLEDGMENTS This work was suggested by Professors Joseph D. Andrade and René S. Ramirez, who also graciously supplied much of the desferrioxamine B.

Submitted on October 24, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics